BFEC
NTLA icon

Benjamin F. Edwards & Company’s Intellia Therapeutics NTLA Stock Holding History

Benjamin F. Edwards & Company’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$1.36M Buy
60,913
+60,052
+6,975% +$1.43M 0.02% 450
2024
Q1 		$24K Buy
+861
New +$23.9K ﹤0.01% 1479
2022
Q4 		– Sell
-100
Closed -$6K – 1886
2022
Q3 		$6K Hold
100
– – ﹤0.01% 1518
2022
Q2 		$5K Sell
100
-100
-50% -$5.08K ﹤0.01% 1551
2022
Q1 		$15K Hold
200
– – ﹤0.01% 1286
2021
Q4 		$24K Buy
+200
New +$25.1K ﹤0.01% 1197
2020
Q4 		– Sell
-550
Closed -$11K – 1708
2020
Q3 		$11K Hold
550
– – ﹤0.01% 1256
2020
Q2 		$12K Hold
550
– – ﹤0.01% 1244
2020
Q1 		$7K Hold
550
– – ﹤0.01% 1372
2019
Q4 		$8K Hold
550
– – ﹤0.01% 1484
2019
Q3 		$7K Sell
550
-2,349
-81% -$37.5K ﹤0.01% 1497
2019
Q2 		$47K Hold
2,899
– – ﹤0.01% 920
2019
Q1 		$50K Buy
2,899
+600
+26% +$8.94K ﹤0.01% 873
2018
Q4 		$31K Hold
2,299
– – ﹤0.01% 966
2018
Q3 		$66K Hold
2,299
– – 0.01% 781
2018
Q2 		$63K Buy
2,299
+341
+17% +$8.26K 0.01% 787
2018
Q1 		$41K Buy
1,958
+671
+52% +$16.5K ﹤0.01% 893
2017
Q4 		$25K Buy
1,287
+425
+49% +$9.81K ﹤0.01% 962
2017
Q3 		$21K Hold
862
– – ﹤0.01% 976
2017
Q2 		$14K Buy
862
+312
+57% +$4.36K ﹤0.01% 983
2017
Q1 		$8K Hold
550
– – ﹤0.01% 1083
2016
Q4 		$7K Hold
550
– – ﹤0.01% 1011
2016
Q3 		$9K Buy
+550
New +$10.6K ﹤0.01% 869

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Benjamin F. Edwards & Company's NTLA Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Intellia Therapeutics (NTLA) stake by 6,975% in Q2 2024, buying an estimated $1.43M and bringing the position to 60,913 shares worth $1.36M. The position accounts for 0.02% of the portfolio, ranked #450.

Benjamin F. Edwards & Company first reported a position in NTLA in Q3 2016 and has held it in 23 quarters since. 291 funds tracked by Wall St. Rank hold NTLA as of Q2 2024.

  • Benjamin F. Edwards & Company held 60,913 shares of Intellia Therapeutics worth $1.36M as of Q2 2024.
  • Benjamin F. Edwards & Company bought 60,052 Intellia Therapeutics shares in Q2 2024, an estimated $1.43M.
  • Intellia Therapeutics made up 0.02% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #450 holding.
  • Benjamin F. Edwards & Company first reported a position in Intellia Therapeutics in Q3 2016 and has held it in 23 quarters since.
  • 291 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.